NAGE today
$2.08-$0.05 (-2.34%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minDescending Triangle
Daily trend turns up above $3.33
Key levels
Resistance$2.58
Resistance$2.38
Support$1.78
Support$1.57
Latest news & SEC filings
DealNiagen Bioscience partners with Truemed for HSA/FSA payment option on injection kits
AnalystFreedom Broker keeps Buy rating on Niagen Bioscience, cuts price target
AnalystCanaccord Genuity keeps Buy rating on Niagen Bioscience, cuts price target
AnalystFreedom Broker keeps Buy rating on Niagen Bioscience, cuts price target to $6
All NAGE news →About Niagen Bioscience
Niagen Bioscience is a bioscience company whose work centers on NAD+ research and the biology of aging. It sells Tru Niagen dietary supplements straight to consumers and via distributors, and supplies its Niagen ingredient in food and drug grades to consumer product makers and to compounding facilities registered with the FDA. The company is also studying a drug candidate for rare conditions linked to advanced aging. It operates in the United States and sells internationally, including across parts of Asia, Europe, and the Middle East.
Based on the company's 10-K filed Mar 4, 2026.
Nasdaq · Healthcare
Niagen Bioscience, Inc. (NAGE)
What Is the Price Target for NAGE?
SEPT Low Target
$9.00
SEPT Mid Target
$10.00
SEPT High Target
$11.00
Analyst Consensus
$10.00
Is NAGE a Buy or Sell Right Now?
Thesis
- •Revenue growing 29.9% YoY with ACCELERATING trend — accelerating momentum.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for NAGE.
Start Free Trial →Is NAGE Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$7.38
67
Moat Score
NARROW
6/9
Piotroski Score
4.5
Altman Z-Score
What Is Smart Money Doing with NAGE?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →NAGE Growth Story
Revenue YoY
29.9%
3yr Revenue CAGR
21.6%
EPS Growth YoY
81.82%
FCF Growth YoY
N/A%
Revenue Trend
ACCELERATING
Dark Pool Trades for NAGE
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for NAGE, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 18:25:29 | $2.08 | 2,041 | $$4K | SELL |
| 18:22:37 | $2.08 | 12,928 | $$27K | SELL |
| 17:38:02 | $2.09 | 2,246 | $$5K | BUY |
| 17:28:21 | $2.09 | 1,000 | $$2K | SELL |
| 17:22:46 | $2.09 | 3,113 | $$7K | SELL |
5 dark pool trades shown · $$44K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Niagen Bioscience, Inc. (NAGE) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →NAGE — frequently asked questions
What is NAGE stock price today?
Niagen Bioscience, Inc. (NAGE) is at $2.08, down 2.34% (-$0.05) at the Nov 13, 2026 close.
Why is NAGE stock moving today?
Latest NAGE news — Nov 13, 2026: Niagen Bioscience partners with Truemed for HSA/FSA payment option on injection kits · Nov 7, 2026: Freedom Broker keeps Buy rating on Niagen Bioscience, cuts price target
What is the NAGE price target?
The average analyst price target for NAGE is $10.00, ranging from $9 to $11, based on 2 analysts. Latest: Canaccord Genuity maintains on Oct 31, 2026.
What do analysts rate NAGE?
Analyst ratings for NAGE: 0 Buy, 3 Hold, 0 Sell — consensus Hold.
Did NAGE beat earnings?
NAGE last reported on Aug 4, 2026: EPS $0.01 vs $0.01 expected — a beat of 20.5%.
What is NAGE's P/E ratio?
NAGE trades at a P/E of 13.1 vs a Healthcare average of 17.7.
Does NAGE pay a dividend?
NAGE does not currently pay a dividend.
What are NAGE support and resistance levels?
Support: $1.78, $1.57, $1.36. Resistance: $2.38, $2.58, $2.80.
What are insiders doing with NAGE?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on NAGE?
Nov 13, 2026: Niagen Bioscience partners with Truemed for HSA/FSA payment option on injection kits · Nov 7, 2026: Freedom Broker keeps Buy rating on Niagen Bioscience, cuts price target · Nov 7, 2026: Canaccord Genuity keeps Buy rating on Niagen Bioscience, cuts price target